Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia.
Tur
M D
MD
Department of Biochemistry, University Hospital Lapeyronie, Montpellier, France.
Garrigue
V
V
Vela
C
C
Dupuy
A M
AM
Descomps
B
B
Cristol
J P
JP
Mourad
G
G
D000328:Adult; D053305:Apolipoprotein C-III; D001054:Apolipoproteins A / Q000097:blood; D001055:Apolipoproteins B / Q000097:blood; D001056:Apolipoproteins C / Q000097:blood* / Q000235:genetics; D001379:Azathioprine / Q000627:therapeutic use; D065095:Calcineurin Inhibitors; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D008875:Middle Aged; D011183:Postoperative Complications; D012016:Reference Values; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D053305:Apolipoprotein C-III; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D001056:Apolipoproteins C; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D001379:Azathioprine; D020123:Sirolimus; D016559:Tacrolimus